Boardroom Alpha
S-1 primary document
BRTX · Registration Statement (Form S-1) · Filed November 18, 2025

Biorestorative Therapies IncS-1 exhibit

ex107.htm

 

EXHIBIT 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

BIORESTORATIVE THERAPIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities and Carry Forward Securities

 

    Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  

Amount

Registered

   Proposed
Maximum
Offering
Price Per
Share
   Maximum
Aggregate
Offering
Price
   Fee
Rate
   Amount of
Registration
Fee
   Carry
Forward
Form
Type
   Carry
Forward
File
Number
   Carry
Forward
Initial
Effective
Date
   Filing Fee
Previously
Paid In
Connection
with Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities 
Fees to Be
Paid
   Equity  Common
Stock,
par value
$0.0001
per share
   457 (o)  508,592 (1)   $1.30 (2)  $661,169.60    0.00013810   $91.31                                               
    Total Offering Amounts        $661,169.60       $91.31                     
    Total Fees Previously Paid                                        
    Total Fee Offsets                                        
    Net Fees Due                  $91.31                      

 

(1) Represents shares of common stock to be sold by the selling securityholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

 

(2) Calculated pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sale prices for our common stock as reported by the NASDAQ Capital Market on November 14, 2025.

 N/A

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer